«Previous Article|Table of Contents|Next Article»

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:

2023 08

Page:

1563-1567

Research Field:

Publishing date:

Info

Title:

Progress in the treatment of retinoblastoma

Author(s):

ZHU Keyu; LIU Chun; WANG Luyao; DUAN Junguo

Eye School of Chengdu University of Traditional Chinese Medicine/Ineye Hospital of Chengdu University of Traditional Chinese Medicine,Sichuan Chengdu 610072,China.

Keywords:

retinoblastoma; infants; treatment

PACS:

R739.7

DOI:

10.3969/j.issn.1672-4992.2023.08.033

Abstract:

Retinoblastoma (RB) is the most common primary malignant tumor in infants and the second largest intraocular malignant tumor.A complete facial appearance and vision are particularly important for children's mental health and life.Therefore,improving eye preservation rate under the premise of ensuring life is the focus of RB treatment.This paper reviewed the current situation of RB treatment worldwide.

References:

£Û1£ÝMATTOSINHO CCS,MOURA A,OIGMAN G,et al.Time to diagnosis of retinoblastoma in Latin America:A systematic review£ÛJ£Ý.Pediatr Hematol Oncol,2019,36(2):55-72.
£Û2£ÝÖлªÒ½Ñ§»áÑÛ¿Æѧ·Ö»áÑ۵ײ¡Ñ§×é,ÖлªÒ½Ñ§»á¶ù¿Æѧ·Ö»áÑÛ¿Æѧ×é,ÖлªÒ½Ñ§»áÑÛ¿Æѧ·Ö»áÑÛÕûÐÎÑÛ¿ô²¡Ñ§×é.ÖйúÊÓÍøĤĸϸ°ûÁöÕï¶ÏºÍÖÎÁÆÖ¸ÄÏ(2019Äê)£ÛJ£Ý.ÖлªÑÛ¿ÆÔÓÖ¾,2019,55(10):726-738. Fundus diseases Group Chinese Society of Ophthalmology Chinese Medical Association,Ophthalmology Group Chinese Society of Pediatric Chinese Medical Association,Oculoplastic & Orbital Group Chinese Society of Ophthalmology Chinese Medical Association.Chinese Guidelines for diagnosis and treatment of retinoblastoma (2019)£ÛJ£Ý.Chinese Journal of Ophthalmology,2019,55(10):726-738.
£Û3£ÝKAMIHARA J,BOURDEAUT F,FOULKES WD,et al.Retinoblastoma and neuroblastoma predisposition and surveillance£ÛJ£Ý.Clin Cancer Res,2017,23(13):e98-e106.
£Û4£ÝHOUSE RJ,HSU ST,THOMAS AS,et al.Vascular findings in a small retinoblastoma tumor using OCT angiography£ÛJ£Ý.Ophthalmol Retina,2019,3(2):194-195.
£Û5£ÝGlobal Retinoblastoma Study Group.Global retinoblastoma presentation and analysis by national income level£ÛJ£Ý.JAMA Oncol,2020,6:685-695.
£Û6£ÝGlobal Retinoblastoma Study Group.The global retinoblastoma outcome study:A prospective,cluster-based analysis of 4064 patients from 149 countries£ÛJ£Ý.Lancet Glob Health,2022,10(8):e1128-e1140.
£Û7£ÝÀîÐãºì,ʯ°²½Ü,ÑîÓñÇí,µÈ.Ë«ÑÛÊÓÍøĤĸϸ°ûÁö46ÀýµÄÁÙ´²Ìص㼰ÁÆЧ£ÛJ£Ý.ÑÛ¿Æѧ±¨,2021,36(9):704-710. LI XH,SHI AJ,YANG YQ,et al.Clinical characteristics and therapeutic effect of 46 cases of bilateral retinoblastoma£ÛJ£Ý.Eye Science,2021,36(9):704-710.
£Û8£ÝºÂ±ù,Àî¼Ñ,ÀîÐãºì,µÈ.118ÀýÊÓÍøĤĸϸ°ûÁöÁÙ´²ÖÎÁÆ·ÖÎö£ÛJ£Ý.µÚÈý¾üÒ½´óѧѧ±¨,2020,42(9):942-947. HAO B,LI J,LI XH,et al.Clinical treatment for retinoblastoma:report of 118 cases£ÛJ£Ý.Journal of Third Military Medical University,2020,42(9):942-947.
£Û9£ÝSHIELDS CL,MASHAYEKHI A,AU AK,et al.The international classification of retinoblastoma predicts chemoreduction success£ÛJ£Ý.Ophthalmology,2006,113(12):2276-2280.
£Û10£ÝPAEZ-ESCAMILLA M,BAGHERI N,TEIRA LE,et al.Intracameral topotecan hydrochloride for anterior chamber seeding of retinoblastoma£ÛJ£Ý.JAMA Ophthalmol,2017,135(12):1453-1454.
£Û11£ÝSHIELDS CL,LALLY SE,LEAHEY AM,et al.Targeted retinoblastoma management:when to use intravenous,intra-arterial,periocular,and intravitreal chemotherapy£ÛJ£Ý.Curr Opin Ophthalmol,2014,25(5):374-385.
£Û12£ÝMUNIER FL,BECK-POPOVIC M,CHANTADA GL,et al.Conservative management of retinoblastoma:Challenging orthodoxy without compromising the state of metastatic grace."Alive,with good vision and no comorbidity"£ÛJ£Ý.Prog Retin Eye Res,2019,73:100764.
£Û13£ÝG¦aND¦aZ AK,MIRZAYEV I,TEMEL E,et al.A 20-year audit of retinoblastoma treatment outcomes£ÛJ£Ý.Eye (Lond),2020,34(10):1916-1924.
£Û14£ÝANAGNOSTE SR,SCOTT IU,MURRAY TG,et al.Rhegmatogenous retinal detachment in retinoblastoma patients undergoing chemoreduction and cryotherapy£ÛJ£Ý.Am J Ophthalmol,2000,129(6):817-819.
£Û15£ÝABRAMSON DH,SCHEFLER AC.Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma:technique and predictors of success£ÛJ£Ý.Ophthalmology,2004,111(5):984-991.
£Û16£ÝASHKENAZY N,DIAZ JD,HANSEN ED,et al.Cyst-like recurrence of retinoblastoma diagnosed by multimodal imaging£ÛJ£Ý.Am J Ophthalmol Case Rep,2022,27:101678.
£Û17£ÝZHENG W,LI X,ZOU H,et al.Dual-target multifunctional superparamagnetic cationic nanoliposomes for multimodal imaging-guided synergistic photothermal/photodynamic therapy of retinoblastoma£ÛJ£Ý.Int J Nanomedicine,2022,17:3217-3237.
£Û18£ÝTEIXO R,LARANJO M,ABRANTES AM,et al.Retinoblastoma:might photodynamic therapy be an option£ÛJ£Ý.Cancer Metastasis Rev,2015,34(4):563-573.
£Û19£ÝBORNFELD N,SCH¨¹LER A,BECHRAKIS N,et al.Preliminary results of primary chemotherapy in retinoblastoma£ÛJ£Ý.Klin Padiatr,1997,209(4):216-221.
£Û20£ÝSHIELDS CL,DE POTTER P,HIMELSTEIN BP,et al.Chemoreduction in the initial management of intraocular retinoblastoma£ÛJ£Ý.Arch Ophthalmol,1996,114(11):1330-1338.
£Û21£ÝFABIAN ID,STACEY AW,JOHNSON KP,et al.Primary intravenous chemotherapy for group D retinoblastoma:a 13-year retrospective analysis£ÛJ£Ý.Br J Ophthalmol,2017,101(1):82-88.
£Û22£ÝSHIELDS CL,BAS Z,LAITON A,et al.Retinoblastoma:emerging concepts in genetics,global disease burden,chemotherapy outcomes,and psychological impact£ÛJ£Ý.Eye (Lond),2022,25:1-8.
£Û23£ÝZENG C,CHEN H,XU Y,et al.Risk factors for chemotherapy-induced vomiting after general anesthesia in children with retinoblastoma:a retrospective study£ÛJ£Ý.Transl Pediatr,2021,10(11):3005-3013.
£Û24£ÝANCONA-LEZAMA D,DALVIN LA,SHIELDS CL.Modern treatment of retinoblastoma:A 2020 review£ÛJ£Ý.Indian J Ophthalmol,2020,68(11):2356-2365.
£Û25£ÝMANJANDAVIDA FP,STATHOPOULOS C,ZHANG J,et al.Intra-arterial chemotherapy in retinoblastoma:A paradigm change£ÛJ£Ý.Indian J Ophthalmol,2019,67(6):740-754.
£Û26£ÝANCONA-LEZAMA D,DALVIN LA,LUCIO-ALVAREZ JA,et al.Ophthalmic vascular events after intra-arterial chemotherapy for retinoblastoma:Real-world comparison between primary and secondary treatments£ÛJ£Ý.Retina,2019,39:2264-2272.
£Û27£ÝÊ׶¼Ò½¿Æ´óѧÑÛ²¿Ö×ÁöÁÙ´²ÕïÁÆÓëÑо¿ÖÐÐÄ,ÖлªÒ½Ñ§»á·ÅÉäѧ·Ö»áÍ·¾±Ñ§×é,ÖлªÒ½Ñ§»á·ÅÉäѧ·Ö»á¶ù¿Æѧ×é.ÊÓÍøĤĸϸ°ûÁöÓ°Ïñ¼ì²éÓëÕï¶Ï¼°Ñ¡ÔñÐÔÑÛ¶¯Âö»¯ÁÆר¼Ò¹²Ê¶£ÛJ£Ý.Öлª·ÅÉäѧÔÓÖ¾,2021,55(5):470-477. Clinical Center for Eye Tumors Capital Medical University,Head and Neck Group Chinese Society of Radiology Chinese Medical Association,Pediatric Group Chinese Society of Radiology Chinese Medical Association.Expert consensus on imaging examination and diagnosis and selective ophthalmic artery infusion in patients with retinoblastoma£ÛJ£Ý.Chinese Journal of Radiology,2021,55(5):470-477.
£Û28£ÝSHIELDS CL,JORGE R,SAY EA,et al.Unilateral retinoblastoma managed with intravenous chemotherapy versus intra-arterial chemotherapy:Outcomes based on the international classification of retinoblastoma£ÛJ£Ý.Asia Pac J Ophthalmol (Phila),2016,5:97-103.
£Û29£ÝMUNIER FL,MOSIMANN P,PUCCINELLI F,et al.First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma:evidence of better visual outcomes,ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment£ÛJ£Ý.Br J Ophthalmol,2017,101(8):1086-1093.
£Û30£ÝÕųϫh,½ðü,Òõ½Ý,µÈ.¾­ÑÛ¶¯ÂöÓë¾­¾²Âö»¯Ñ§ÁÆ·¨ÖÎÁƵ¥ÑÛDÆÚÊÓÍøĤĸϸ°ûÁöµÄÁÙ´²Ñо¿£ÛJ£Ý.ÖлªÑÛ¿ÆҽѧÔÓÖ¾£¨µç×Ӱ棩,2021,11(2):70-75. ZHANG CY,JIN M,YIN J,et al.The effect of intravenous chemotherapy and intra-arterial chemotherapy for unilateral group D retinoblastoma£ÛJ£Ý.Chinese Journal of Ophthalmologic Medicine (Electronic Edition),2021,11(2):70-75.
£Û31£ÝÏĽܾü,ÕÔ¾üÑô,·¶Èô˼,µÈ.¾­ÑÛ¶¯Âö¹à×¢»¯ÁÆÖÎÁÆÊÓÍøĤĸϸ°ûÁö320ÀýµÄÁÙ´²Ñо¿£ÛJ£Ý.Öлª½éÈë·ÅÉäѧµç×ÓÔÓÖ¾,2020,8(3):211-215. XIA JJ,ZHAO JY,FAN RS,et al.The clinical study of intra-arterial chemotherapy in 320 patients with retinoblastoma£ÛJ£Ý.Chinese Journal of Interventional Radiology,2020,8(3):211-215.
£Û32£ÝLIANG T,ZHANG X,LI J,et al.Intra-arterial chemotherapy as primary treatment for advanced unilateral retinoblastoma in China£ÛJ£Ý.Front Med (Lausanne),2022,9:855661.
£Û33£ÝZENG C,HAN M,FAN J,et al.Anemia and bone marrow suppression after intra-arterial chemotherapy in children with retinoblastoma:A retrospective analysis£ÛJ£Ý.Front Oncol,2022,12:848877.
£Û34£ÝSHIELDS CL,MANJANDAVIDA FP,AREPALLI S,et al.Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds:Preliminary results£ÛJ£Ý.JAMA Ophthalmol,2014,132:319-325.
£Û35£ÝSCHAIQUEVICH P,FRANCIS JH,CANCELA MB,et al.Treatment of retinoblastoma:What is the latest and what is the future£ÛJ£Ý.Front Oncol,2022,12:822330.
£Û36£ÝSHIELDS CL,ALSET AE,SAY EA,et al.Retinoblastoma control with primary intra-arterial chemotherapy:Outcomes before and during the intravitreal chemotherapy era£ÛJ£Ý.J Pediatr Ophthalmol Strabismus,2016,53(5):275-284.
£Û37£ÝXUE K,REN H,MENG F,et al.Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients£ÛJ£Ý.BMC Ophthalmol,2019,19(1):61.
£Û38£ÝLIANG TY,ZHU XY,HUA XM,et al.Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma£ÛJ£Ý.Int J Ophthalmol,2020,13(2):257-262.
£Û39£ÝYU MD,DALVIN LA,WELCH RJ,et al.Precision intravitreal chemotherapy for localized vitreous seeding of retinoblastoma£ÛJ£Ý.Ocul Oncol Pathol,2019,5:284-289.
£Û40£ÝMUNIER FL,GAILLARD MC,DECEMBRINI S,et al.Intracameral chemotherapy (Melphalan) for aqueous seeding in retinoblastoma:Bicameral injection technique and related toxicity in a pilot case study£ÛJ£Ý.Ocul Oncol Pathol,2017,3(2):149-155.
£Û41£ÝMUNIER FL,MOULIN A,GAILLARD MC,et al.Intracameral chemotherapy for globe salvage in retinoblastoma with secondary anterior chamber invasion£ÛJ£Ý.Ophthalmology,2018,125(4):615-617.
£Û42£ÝPRADHAN DG,SANDRIDGE AL,MULLANEY P,et al.Radiation therapy for retinoblastoma:a retrospective review of 120 patients£ÛJ£Ý.Int J Radiat Oncol Biol Phys,1997,39(1):3-13.
£Û43£ÝSARICI AM,CELKAN TT,OTO BB,et al.Episcleral iodine-125 radioactive plaque brachytherapy as a salvage treatment for retinoblastoma in the era of intraarterial chemotherapy£ÛJ£Ý.Turk J Pediatr,2022,64(2):285-292.
£Û44£ÝFRANCIS JH,BARKER CA,WOLDEN SL,et al.Salvage/adjuvant brachytherapy after ophthalmic artery chemosurgery for intraocular retinoblastoma£ÛJ£Ý.Int J Radiat Oncol Biol Phys,2013,87(3):517-523.
£Û45£ÝKAEWKHAW R,ROJANAPORN D.Retinoblastoma:Etiology,modeling,and treatment£ÛJ£Ý.Cancers (Basel),2020,12(8):2304.
£Û46£ÝSTURMLECHNER I,ZHANG C,SINE CC,et al.P21 produces a bioactive secretome that places stressed cells under immunosurveillance£ÛJ£Ý.Science,2021,374(6567):eabb3420.
£Û47£ÝENGELAND K.Cell cycle regulation:p53-p21-RB signaling£ÛJ£Ý.Cell Death Differ,2022,29(5):946-960.
£Û48£ÝLAURIE NA,DONOVAN SL,SHIH CS,et al.Inactivation of the p53 pathway in retinoblastoma£ÛJ£Ý.Nature,2006,444(7115):61-66.
£Û49£ÝREED D,SHEN Y,SHELAT AA,et al.Identification and characterization of the first small molecule inhibitor of MDMX£ÛJ£Ý.J Biol Chem,2010,285(14):10786-10796.
£Û50£ÝASSAYAG F,NICOLAS A,VACHER S,et al.Combination of carboplatin and bevacizumab is an efficient therapeutic approach in retinoblastoma patient-derived xenografts£ÛJ£Ý.Invest Ophthalmol Vis Sci,2016,57(11):4916-4926.
£Û51£ÝPASCUAL-PASTO G,BAZAN-PEREGRINO M,OLACIREGUI NG,et al.Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01£ÛJ£Ý.Sci Transl Med,2019,11(476):eaat9321.

Memo

Memo:

National Natural Science Foundation of China£¨No.82074335£©;¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð×ÊÖúÏîÄ¿£¨±àºÅ£º82074335£©

Common functions

Last Update: 1900-01-01